Qianjiang Yongan Pharmaceutical Co Ltd
SZSE:002365
Wall Street
Price Targets
Price Targets Summary
Qianjiang Yongan Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Qianjiang Yongan Pharmaceutical Co Ltd is 18.9 CNY .
Price Targets
Revenue
Forecast
Revenue Estimate
Qianjiang Yongan Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Qianjiang Yongan Pharmaceutical Co Ltd's revenue is 10%. The projected CAGR for the next 7 years is -12%.
Operating Income
Forecast
Operating Income Estimate
Qianjiang Yongan Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Qianjiang Yongan Pharmaceutical Co Ltd's operating income is 29%. The projected CAGR for the next 7 years is -24%.
Net Income
Forecast
Net Income Estimate
Qianjiang Yongan Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Qianjiang Yongan Pharmaceutical Co Ltd's net income is 20%. The projected CAGR for the next 7 years is -21%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Qianjiang Yongan Pharmaceutical Co Ltd's stock price target?
Price Target
18.9
CNY
According to Wall Street analysts, the average 1-year price target for Qianjiang Yongan Pharmaceutical Co Ltd is 18.9 CNY .
What is Qianjiang Yongan Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-12%
For the last 8 years the compound annual growth rate for Qianjiang Yongan Pharmaceutical Co Ltd's revenue is 10%. The projected CAGR for the next 7 years is -12%.
What is Qianjiang Yongan Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-24%
For the last 8 years the compound annual growth rate for Qianjiang Yongan Pharmaceutical Co Ltd's operating income is 29%. The projected CAGR for the next 7 years is -24%.
What is Qianjiang Yongan Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-21%
For the last 8 years the compound annual growth rate for Qianjiang Yongan Pharmaceutical Co Ltd's net income is 20%. The projected CAGR for the next 7 years is -21%.